128 related articles for article (PubMed ID: 2605168)
1. Conformation of DNA modified at a d(GG) or a d(AG) site by the antitumor drug cis-diamminedichloroplatinum(II).
Schwartz A; Marrot L; Leng M
Biochemistry; 1989 Oct; 28(20):7975-9. PubMed ID: 2605168
[TBL] [Abstract][Full Text] [Related]
2. Chemical probes of the conformation of DNA modified by cis-diamminedichloroplatinum(II).
Marrot L; Leng M
Biochemistry; 1989 Feb; 28(4):1454-61. PubMed ID: 2719908
[TBL] [Abstract][Full Text] [Related]
3. DNase I footprinting of cis- or trans-diamminedichloroplatinum(II)-modified DNA.
Schwartz A; Leng M
J Mol Biol; 1994 Mar; 236(4):969-74. PubMed ID: 8120904
[TBL] [Abstract][Full Text] [Related]
4. RNA polymerases react differently at d(ApG) and d(GpG) adducts in DNA modified by cis-diamminedichloroplatinum(II).
Corda Y; Anin MF; Leng M; Job D
Biochemistry; 1992 Feb; 31(7):1904-8. PubMed ID: 1536834
[TBL] [Abstract][Full Text] [Related]
5. Transcription by eucaryotic and procaryotic RNA polymerases of DNA modified at a d(GG) or a d(AG) site by the antitumor drug cis-diamminedichloroplatinum(II).
Corda Y; Job C; Anin MF; Leng M; Job D
Biochemistry; 1991 Jan; 30(1):222-30. PubMed ID: 1988023
[TBL] [Abstract][Full Text] [Related]
6. Distortions induced in DNA by cis-platinum interstrand adducts.
Sip M; Schwartz A; Vovelle F; Ptak M; Leng M
Biochemistry; 1992 Mar; 31(9):2508-13. PubMed ID: 1547234
[TBL] [Abstract][Full Text] [Related]
7. Replication inhibition and translesion synthesis on templates containing site-specifically placed cis-diamminedichloroplatinum(II) DNA adducts.
Comess KM; Burstyn JN; Essigmann JM; Lippard SJ
Biochemistry; 1992 Apr; 31(16):3975-90. PubMed ID: 1314653
[TBL] [Abstract][Full Text] [Related]
8. DNA conformational change produced by the site-specific interstrand cross-link of trans-diamminedichloroplatinum(II).
Brabec V; Síp M; Leng M
Biochemistry; 1993 Nov; 32(43):11676-81. PubMed ID: 8218235
[TBL] [Abstract][Full Text] [Related]
9. DNA unwinding produced by site-specific intrastrand cross-links of the antitumor drug cis-diamminedichloroplatinum(II).
Bellon SF; Coleman JH; Lippard SJ
Biochemistry; 1991 Aug; 30(32):8026-35. PubMed ID: 1868076
[TBL] [Abstract][Full Text] [Related]
10. Conformational rearrangement of 1,2-d(GG) intrastrand cis-diammineplatinum crosslinked DNA is driven by counter-ion penetration within the minor groove of the modified site.
Gantchev TG; Petkov PS; Hunting DJ
J Mol Model; 2017 Sep; 23(10):278. PubMed ID: 28913561
[TBL] [Abstract][Full Text] [Related]
11. Effects of the anticancer drug cis-diamminedichloroplatinum(II) on the activities of calf thymus DNA polymerase epsilon.
Huang L; Turchi JJ; Wahl AF; Bambara RA
Biochemistry; 1993 Jan; 32(3):841-8. PubMed ID: 8380711
[TBL] [Abstract][Full Text] [Related]
12. DNA bending and unwinding due to the major 1,2-GG intrastrand cross-link formed by antitumor cis-diamminedichloroplatinum(II) are flanking-base independent.
Stehlikova K; Kostrhunova H; Kasparkova J; Brabec V
Nucleic Acids Res; 2002 Jul; 30(13):2894-8. PubMed ID: 12087174
[TBL] [Abstract][Full Text] [Related]
13. HMG-domain protein recognition of cisplatin 1,2-intrastrand d(GpG) cross-links in purine-rich sequence contexts.
Cohen SM; Mikata Y; He Q; Lippard SJ
Biochemistry; 2000 Sep; 39(38):11771-6. PubMed ID: 10995245
[TBL] [Abstract][Full Text] [Related]
14. NMR solution structure of a DNA decamer containing an interstrand cross-link of the antitumor drug cis-diamminedichloroplatinum (II).
Paquet F; Pérez C; Leng M; Lancelot G; Malinge JM
J Biomol Struct Dyn; 1996 Aug; 14(1):67-77. PubMed ID: 8877563
[TBL] [Abstract][Full Text] [Related]
15. Chemical and biological studies of the major DNA adduct of cis-diamminedichloroplatinum(II), cis-[Pt(NH3)2(d(GpG]], built into a specific site in a viral genome.
Naser LJ; Pinto AL; Lippard SJ; Essigmann JM
Biochemistry; 1988 Jun; 27(12):4357-67. PubMed ID: 3166983
[TBL] [Abstract][Full Text] [Related]
16. Distortions induced in double-stranded oligonucleotides by the binding of cis- or trans-diammine-dichloroplatinum(II) to the d(GTG) sequence.
Anin MF; Leng M
Nucleic Acids Res; 1990 Aug; 18(15):4395-400. PubMed ID: 2388824
[TBL] [Abstract][Full Text] [Related]
17. Formation of cis-diamminedichloroplatinum(II) 1,2-intrastrand cross-links on DNA is flanking-sequence independent.
Burstyn JN; Heiger-Bernays WJ; Cohen SM; Lippard SJ
Nucleic Acids Res; 2000 Nov; 28(21):4237-43. PubMed ID: 11058123
[TBL] [Abstract][Full Text] [Related]
18. Instability of the monofunctional adducts in cis-[Pt(NH3)2(N7-N-methyl-2-diazapyrenium)Cl](2+)-modified DNA: rates of cross-linking reactions in cis-platinum-modified DNA.
Payet D; Gaucheron F; Sip M; Leng M
Nucleic Acids Res; 1993 Dec; 21(25):5846-51. PubMed ID: 8290343
[TBL] [Abstract][Full Text] [Related]
19. Base sequence-independent distorsions induced by interstrand cross-links in cis-diamminedichloroplatinum (II)-modified DNA.
Malinge JM; Pérez C; Leng M
Nucleic Acids Res; 1994 Sep; 22(19):3834-9. PubMed ID: 7937101
[TBL] [Abstract][Full Text] [Related]
20. Effect of single DNA lesions on in vitro replication with DNA polymerase III holoenzyme. Comparison with other polymerases.
Belguise-Valladier P; Maki H; Sekiguchi M; Fuchs RP
J Mol Biol; 1994 Feb; 236(1):151-64. PubMed ID: 8107100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
